Free Trial

Celldex Therapeutics (CLDX) Short Interest Ratio & Short Volume

$34.03
-0.19 (-0.56%)
(As of 12:37 PM ET)

Celldex Therapeutics Short Interest Data

Current Short Interest
6,620,000 shares
Previous Short Interest
6,990,000 shares
Change Vs. Previous Month
-5.29%
Dollar Volume Sold Short
$265.93 million
Short Interest Ratio
7.4 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
65,910,000 shares
Percentage of Shares Shorted
10.04%
Today's Trading Volume
167,464 shares
Average Trading Volume
809,820 shares
Today's Volume Vs. Average
21%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Celldex Therapeutics ?

Sign up to receive the latest short interest report for Celldex Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CLDX Short Interest Over Time

CLDX Days to Cover Over Time

CLDX Percentage of Float Shorted Over Time

Celldex Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/20246,620,000 shares $265.93 million -5.3%N/A7.4 $40.17
4/30/20246,990,000 shares $261.57 million +3.6%N/A7.7 $37.42
4/15/20246,750,000 shares $263.72 million +2.9%N/A7.3 $39.07
3/31/20246,560,000 shares $275.32 million +11.2%N/A6.9 $41.97
3/15/20245,900,000 shares $247.86 million -8.0%N/A6.4 $42.01
2/29/20246,410,000 shares $308.06 million -7.6%N/A7.4 $48.06
2/15/20246,940,000 shares $255.39 million +3.4%N/A9.3 $36.80
1/31/20246,710,000 shares $236.33 million +7.9%N/A8.5 $35.22
1/15/20246,220,000 shares $261.49 million -5.6%N/A7.6 $42.04
12/31/20236,590,000 shares $261.36 million -10.3%N/A8.6 $39.66
12/15/20237,350,000 shares $273.05 million -8.9%N/A9.6 $37.15
11/30/20238,070,000 shares $243.79 million +2.4%N/A11.1 $30.21
11/15/20237,880,000 shares $224.82 million +40.2%N/A11.3 $28.53
10/31/20235,620,000 shares $132.18 million +0.9%N/A9.2 $23.52
10/15/20235,570,000 shares $145.60 million -3.3%N/A12.1 $26.14
9/30/20235,760,000 shares $158.52 million -5.4%N/A13.1 $27.52
9/15/20236,090,000 shares $170.22 million -3.3%N/A14.3 $27.95
8/31/20236,300,000 shares $175.77 million -3.7%N/A13.5 $27.90
8/15/20236,540,000 shares $205.55 million +8.5%N/A14.3 $31.43
7/31/20236,030,000 shares $213.22 million -3.8%N/A13.8 $35.36
7/15/20236,270,000 shares $233.81 million +1.8%N/A13.5 $37.29
6/30/20236,160,000 shares $209.01 million +2.7%N/A11 $33.93
6/15/20236,000,000 shares $221.22 million +3.5%N/A9.8 $36.87
5/31/20235,800,000 shares $184.44 million +7.0%N/A9.3 $31.80
5/15/20235,420,000 shares $185.69 million +1.1%N/A8.4 $34.26
4/30/20235,360,000 shares $168.52 million +3.5%N/A8.4 $31.44
4/15/20235,180,000 shares $156.90 million -1.7%N/A8.6 $30.29
3/31/20235,270,000 shares $189.61 million +38.0%N/A9.9 $35.98
3/15/20233,820,000 shares $167.13 million +5.5%N/A8 $43.75
2/28/20233,620,000 shares $154.90 million +4.3%N/A7.5 $42.79
2/15/20233,470,000 shares $148.79 million +4.5%N/A7.7 $42.88
1/31/20233,320,000 shares $146.28 million -4.3%N/A6.8 $44.06
1/15/20233,470,000 shares $159.69 million +1.8%N/A7 $46.02
12/30/20223,410,000 shares $151.98 million -17.2%N/A6.8 $44.57
12/15/20224,120,000 shares $182.47 million +1.7%N/A8 $44.29
11/30/20224,050,000 shares $150.21 million -1.9%N/A9 $37.09
11/15/20224,130,000 shares $151.53 million -8.2%N/A9 $36.69
10/31/20224,500,000 shares $158.09 million -0.9%N/A9.7 $35.13
10/15/20224,540,000 shares $142.74 million -1.5%N/A9.3 $31.44
9/30/20224,610,000 shares $129.59 million +2.4%N/A9 $28.11
Must-See: Elon’s New Invention is Absolutely Insane (Ad)

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…
9/15/20224,500,000 shares $136.40 million +2.3%N/A6.2 $30.31
8/31/20224,400,000 shares $133.76 million +4.0%N/A5.6 $30.40
8/15/20224,230,000 shares $158.92 million +14.3%N/A5.1 $37.57
7/31/20223,700,000 shares $113.66 million -2.9%30.7%4.3 $30.72
7/15/20223,810,000 shares $111.79 million -0.3%31.6%4.5 $29.34
6/30/20223,820,000 shares $102.99 million -18.9%31.7%4.7 $26.96
6/15/20224,710,000 shares $104.99 million +1.5%39.0%7.3 $22.29
5/31/20224,640,000 shares $109.13 million -5.5%N/A8 $23.52
5/15/20224,910,000 shares $147.25 million -1.0%N/A8.7 $29.99
4/30/20224,960,000 shares $151.53 million -9.3%N/A9 $30.55
4/15/20225,470,000 shares $196.04 million -0.2%N/A9.8 $35.84
3/31/20225,480,000 shares $186.65 million -8.7%N/A9.3 $34.06
3/15/20226,000,000 shares $187.26 million +3.3%N/A10.3 $31.21
2/28/20225,810,000 shares $173.72 million +11.7%N/A10 $29.90
2/15/20225,200,000 shares $169.78 million +2.4%N/A9.4 $32.65
1/31/20225,080,000 shares $157.53 million +3.3%N/A9.9 $31.01
1/15/20224,920,000 shares $157.00 million +3.1%N/A0 $31.91
12/31/20214,770,000 shares $184.31 million +9.9%N/A10.6 $38.64
12/15/20214,340,000 shares $166.92 million +6.6%N/A10.1 $38.46
11/30/20214,070,000 shares $155.07 million +12.4%N/A9.7 $38.10
11/15/20213,620,000 shares $155.70 million -2.7%N/A8.2 $43.01
10/29/20213,720,000 shares $158.25 million +25.7%N/A7.9 $42.54
10/15/20212,960,000 shares $136.69 million -0.7%N/A5.7 $46.18
9/30/20212,980,000 shares $160.89 million -11.0%N/A3.8 $53.99
9/15/20213,350,000 shares $178.25 million -15.4%N/A3.7 $53.21
8/31/20213,960,000 shares $208.49 million -8.1%N/A4.4 $52.65
8/13/20214,310,000 shares $188.43 million +15.2%N/A4.9 $43.72
7/30/20213,740,000 shares $163.63 million +11.6%N/A4.5 $43.75
7/15/20213,350,000 shares $146.93 million +19.2%N/A4.2 $43.86
6/30/20212,810,000 shares $93.97 million +11.1%7.3%4.1 $33.44
6/15/20212,530,000 shares $73.88 million -18.4%6.6%4.4 $29.20
5/28/20213,100,000 shares $86.65 million -3.7%8.1%5.3 $27.95
5/14/20213,220,000 shares $80.53 million -3.0%N/A5.2 $25.01
4/30/20213,320,000 shares $103.82 million -3.8%N/A5 $31.27
4/15/20213,450,000 shares $76.83 million -3.1%N/A4.9 $22.27
3/31/20213,560,000 shares $70.24 million +24.9%N/A4.9 $19.73
3/15/20212,850,000 shares $72.33 million -0.7%N/A4.3 $25.38
2/26/20212,870,000 shares $78.95 million -16.6%N/A4.4 $27.51
2/12/20213,440,000 shares $81.70 million -2.0%N/A4.9 $23.75
1/29/20213,510,000 shares $72.80 million -1.7%N/A5.2 $20.74
1/15/20213,570,000 shares $64.19 million -25.8%N/A5.6 $17.98
12/31/20204,810,000 shares $86.00 million +118.6%N/A7.9 $17.88
12/15/20202,200,000 shares $40.13 million -9.5%N/A3 $18.24
11/30/20202,430,000 shares $55.28 million -13.8%N/A3.4 $22.75
11/15/20202,820,000 shares $56.32 million -5.4%N/A4.1 $19.97
10/30/20202,980,000 shares $45.83 million -8.0%N/A4.5 $15.38
10/15/20203,240,000 shares $52.91 million -1.5%N/A4.6 $16.33
9/30/20203,290,000 shares $48.79 million +9.7%N/A4.3 $14.83
9/15/20203,000,000 shares $35.19 million +23.5%N/A4.4 $11.73
8/31/20202,430,000 shares $29.01 million +102.5%N/A0.9 $11.94
Must-See: Elon’s New Invention is Absolutely Insane (Ad)

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…
8/14/20201,200,000 shares $12.37 million +52.5%N/A0.4 $10.31
7/31/2020787,000 shares $8.10 million -17.3%N/A0.3 $10.29
7/15/2020951,200 shares $10.21 million -37.8%N/A0.3 $10.73
6/30/20201,530,000 shares $19.89 million -33.8%N/A0.6 $13.00
6/15/20202,310,000 shares $24.74 million +668.2%N/A0.9 $10.71
5/29/2020300,700 shares $796,855.00 +13.8%N/A0.7 $2.65
5/15/2020264,200 shares $597,092.00 -13.9%N/A0.7 $2.26
4/30/2020306,700 shares $751,415.00 -2.6%N/A0.7 $2.45
4/15/2020314,900 shares $588,863.00 -2.4%N/A0.8 $1.87
3/31/2020322,500 shares $970,725.00 -22.3%N/A1 $3.01
3/13/2020415,100 shares $751,331.00 +8.9%N/A2.1 $1.81
2/28/2020381,100 shares $594,516.00 +56.1%N/A1.3 $1.56
2/14/2020244,100 shares $539,461.00 -8.2%N/A0.9 $2.21
1/31/2020266,000 shares $694,260.00 -6.3%N/A1.9 $2.61
1/15/2020283,900 shares $652,970.00 -8.4%N/A1.8 $2.30
12/31/2019309,800 shares $709,442.00 -11.7%N/A2.1 $2.29
9/15/2019594,300 shares $1.28 million -33.5%4.0%4 $2.16
8/15/20191,190,500 shares $2.76 million +16.6%9.9%5.3 $2.32

CLDX Short Interest - Frequently Asked Questions

What is Celldex Therapeutics' current short interest?

Short interest is the volume of Celldex Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 6,620,000 shares of CLDX short. Learn More on Celldex Therapeutics' current short interest.

What is a good short interest ratio for Celldex Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CLDX shares currently have a short interest ratio of 7.0. Learn More on Celldex Therapeutics's short interest ratio.

Which institutional investors are shorting Celldex Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Celldex Therapeutics: Walleye Trading LLC, Ikarian Capital LLC, Concourse Financial Group Securities Inc., and Goldman Sachs Group Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Celldex Therapeutics' short interest increasing or decreasing?

Celldex Therapeutics saw a decline in short interest in May. As of May 15th, there was short interest totaling 6,620,000 shares, a decline of 5.3% from the previous total of 6,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Celldex Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies compare to Celldex Therapeutics: Intellia Therapeutics, Inc. (15.73%), Neogen Co. (9.03%), Riot Platforms, Inc. (17.46%), Aspira Women's Health Inc. (2.18%), Lantheus Holdings, Inc. (6.46%), Exact Sciences Co. (4.61%), Repligen Co. (8.38%), Exelixis, Inc. (3.77%), Halozyme Therapeutics, Inc. (6.80%), Ionis Pharmaceuticals, Inc. (6.43%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Celldex Therapeutics stock?

Short selling CLDX is an investing strategy that aims to generate trading profit from Celldex Therapeutics as its price is falling. CLDX shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Celldex Therapeutics?

A short squeeze for Celldex Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CLDX, which in turn drives the price of the stock up even further.

How often is Celldex Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLDX, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:CLDX) was last updated on 5/30/2024 by MarketBeat.com Staff

From Our Partners